The prevalence of eye diseases in the elderly population is a global problem of modernity

Capa

Citar

Texto integral

Resumo

The priority problem of various industrial and developing countries, which largely determine the health of the population and, above all, older age groups, is currently eye diseases. Most modern researchers consider age-related macular degeneration, glaucoma, and cataracts to be eye diseases. Socially significant eye diseases have a high prevalence and are the leading cause of blindness in various countries. Authors analyzed the prevalence of glaucoma, age-related macular degeneration, and cataracts according to domestic and foreign publications in recent years.

The results of the studies considered in the scientific review indicate a continuing gain in socially significant eye diseases, the frequency of which increases with age. The high incidence of the studied pathology is observed in China, India, and Russia. The study shows socially significant eye diseases to be the most critical problem in various countries, including the Russian Federation. The relevance of this pathology will increase due to the ongoing aging of the population and an increase in their share in the demographic structure of many states. The high prevalence of age-related macular degeneration, cataracts, and glaucoma leads to an increase in the number of people on the planet with complete or partial vision loss, which significantly disrupts their social functioning and requires significant financial costs for treatment and ensuring an acceptable level and quality of life. The data presented in the review and obtained results are of practical importance for the organization of monitoring of eye diseases and the development of an appropriate state and health strategy.

Sobre autores

Dmitry Konyaev

Tambov branch of S.N. Fedorov NMRC MNTK “Eye microsurgery” Tambov

Autor responsável pela correspondência
Email: noemail@neicon.ru
ORCID ID: 0000-0003-3779-998X
Rússia

Evgenia Popova

Tambov branch of S.N. Fedorov NMRC MNTK “Eye microsurgery” Tambov

Email: noemail@neicon.ru
ORCID ID: 0000-0001-5845-3414
Rússia

Anton Titov

South-west State University

Email: vitalaxen@mail.ru
ORCID ID: 0000-0003-4209-3930

MD, post-graduate student, Department of biomedical engineering, SouthWest State University, Kursk, 305040, Russian Federation.

e-mail: vitalaxen@mail.ru

Rússia

Nikolay Agarkov

South-west State University; Belgorod National Research University

Email: noemail@neicon.ru
ORCID ID: 0000-0002-4821-3692
Rússia

Maksim Yablokov

Tambov branch of S.N. Fedorov NMRC MNTK “Eye microsurgery” Tambov

Email: noemail@neicon.ru
ORCID ID: 0000-0001-7902-0589
Rússia

Vitaly Aksenov

South-west State University

Email: noemail@neicon.ru
ORCID ID: 0000-0002-6516-1871
Rússia

Bibliografia

  1. Brezhnev A.Yu., Baranov V.I., Kuroedov A.V. Pseudoexfoliative glaucoma vs primary open angle glaucoma. Oftal’mologicheskie vedomosti. 2012; 5(4): 45–50. (in Russian)
  2. Cheung N., Teo K., Zhao W., Wang J.J., Neelam K., Tan N.Y.Q., et al. Prevalence and associations of retinal emboli with ethnicity, stroke, and renal disease in a multiethnic Asian population: The Singapore Epidemiology of Eye Disease Study. JAMA Ophthalmol. 2017; 135(10): 1023–8. https://doi.org/10.1001/jamaophthalmol.2017.2972
  3. Haddad M.F., Bakkar M.M., Abdo N. Public awareness of common eye diseases in Jordan. BMC Ophthalmol. 2017; 17(1): 177. https://doi.org/10.1186/s12886-017-0575-3
  4. Kamga H., McCusker J., Yafee M., Sewitch M., Sussman T., Strumpf E., et al. Self-care tools to treat depressive symptoms in patients with age-related eye disease: a randomized controlled clinical trial. Clin. Exp. Ophthalmol. 2017; 45(4): 371–8. https://doi.org/10.1111/ceo.12890
  5. Al-Bahlal A., Khandekar R., Al Rubaie K., Alzahim T., Edward D.P., Kozak I. Changing epidemiology of neovascular glaucoma from 2002 to 2012 at King Khaled Eye Specialist Hospital, Saudi Arabia. Indian J. Ophthalmol. 2017; 65(10): 969–73. https://doi.org/10.4103/ijo.ijo_33_17
  6. Vitale S., Clemons T.E., Agrón E., Ferris F.L., Domalpally A., Danis R.P., et al. Evaluating the validity of the age-related eye disease study grading scale for age-related macular degeneration: AREDS2 Report 10. JAMA Ophthalmol. 2016; 134(9): 1041–7. https://doi.org/10.1001/jamaophthalmol.2016.2383
  7. Alikova T.T., Alikova Z.R., Fidarova K.K., Yakh”eva Z.I. The incidence of glaucoma and clinical supervision. Mezhdunarodnyy zhurnal prikladnykh i fundamental’nykh issledovaniy. 2016; (8-2): 149–52. (in Russian)
  8. Nikiforova E.B. The clinical epidemiological analysis of dynamics of eye incidence, disability and the stationary ophthalmological help to the population of the samara region during 2010-2014 years. Vestnik Orenburgskogo gosudarstvennogo universiteta. 2015; (12): 160–6. (in Russian)
  9. Saldanha I.J., Lindsley K., Do D.V., Chuck R.S., Meyerle C., Jones L.S., et al. Comparison of clinical trial and systematic review outcomes for the 4 most prevalent eye diseases. JAMA Ophthalmol. 2017; 135(9): 933–40. https://doi.org/10.1001/jamaophthalmol.2017.2583
  10. Dolgova I.G., Shchepin V.O., Proklova T.N. Features of adaptation of the system of balanced indicators for evaluating the effectiveness of the process-oriented approach in the regional system of organization of ophthalmological care. Byulleten’ Natsional’nogo nauchno-issledovatel’skogo instituta obshchestvennogo zdorov’ya imeni N.A. Semashko. 2016; (1-2): 48–55. (in Russian)
  11. Komarovskikh E.N., Polapina A.A. Age-related cataract: epidemiology, risk factors, cataractogenesis aspects (problem statement). MEDICUS. 2016; (2): 66–70. (in Russian)
  12. Indaram M., Ma W., Zhao L., Fariss R.N., Rodriguez I.R., Wong W.T. 7-Ketocholesterol increases retinal microglial migration, activation, and angiogenicity: a potential pathogenic mechanism underlying age-related macular degeneration. Sci. Rep. 2015; (5): 9144. https://doi.org/10.1038/srep09144
  13. Kang J.H., Wu J., Cho E., Ogata S., Jacques P., Taylor A., et al. Contribution of the nurses’ health study to the epidemiology of cataract, age-related macular degeneration, and glaucoma. Am. J. Public Health. 2016; 106(9): 1684–9. https://doi.org/10.1038/srep09144
  14. Vijaya L., Asokan R., Panday M., Choudhari N.S., Ramesh S.V., Velumuri L., et al. Six-year in cadence of angle-closure diseaseina South Indian population: the Chennai Eye Disease Incidence Study. Am. J. Ophthalmol. 2013; 156(6): 1308–15.e2. https://doi.org/10.1016/j.ajo.2013.07.027
  15. Parisi A.V., Downs N. Cloud cover and horizontal plane eye damaging solar UV exposures. Int. J. Biometeorol. 2004; 49(2): 130–6. https://doi.org/10.1007/s00484-004-0213-7
  16. Pizzarello L., Abiose A., Ffytche T., Duerksen R., Thulasiraj R., Taylor H., et al. Vision 2020: The Right to Sight. A global initiative to eliminate avoidable blindness. Arch. Ophthalmol. 2004; 122(4): 615–20. https://doi.org/10.1001/archopht.122.4.615
  17. Brachevskiy S.L., Malyugin B.E. Incidence of visual impairment due to cataract according to the RAAB study in Samara. Oftal’mokhirurgiya. 2013; (3): 82–5. (in Russian)
  18. Limburg H., Barria von-Bischhoffhausen F., Gomes P., Silva J.C., Foster A. Review of recent surveys on blindness and visual impairment in Latin America. Br. J. Ophthalmol. 2008; 92(3): 315–9. https://doi.org/10.1136/bjo.2007.125906
  19. Control of Major Blinding Diseases and Disorders. Vision 2020: The Right to Sight. WHO; 2010.
  20. Congdon N., Vingerling J.R., Klein B.E., West S., Friedman D.S., Kempen J., et al. Prevalence of cataract and pseudophakia/aphakia among adults in the United States. Arch. Ophthalmol. 2004; 122(4): 487–94. https://doi.org/10.1001/archopht.122.4.487
  21. Daien V., Le Pape A., Heve D., Carriere I., Villain M. Incidence, risk factors, and impact of age on retinal detachment after cataract surgery in France: A National Population Study. Ophthalmology. 2015; 122(11): 2179–85. https://doi.org/10.1016/j.ophtha.2015.07.014
  22. Lewallen M., Xie T. Cell-based therapies for retinal degenerative diseases: a thousand strategies. J. Glaucoma. 2013; 22(Suppl. 5): S42–5. https://doi.org/10.1097/ijg.0b013e3182934b45
  23. Kuang T.M., Tsai S.Y., Liu C.J., Ko Y.C., Lee S.M., Chou P. Changes in refractive status in an elderly Chinese population in a 7-year follow-up: The Shihpai Eye Study. J. Chin. Med. Assoc. 2017; 80(10): 673–8. https://doi.org/10.1016/j.jcma.2017.06.004
  24. Tang M., Ding X., Li J., Hu A., Yuan M., Yang Y. Novel mutations in FZD4 and phenotype-genotype correlation in Chinese patients with familial exudative vitreoretinopathy. Mol. Vis. 2016; 22: 917–32.
  25. Babalola O.E., Murdoch I.E., Cousens S., Abiose A., Jones B. Blindness: how to assess numbers and causes? Br. J. Ophthalmol. 2003; 87(3): 282–4. https://doi.org/10.1136/bjo.87.3.282
  26. Chua J., Baskaran M., Ong P.G., Zheng Y., Wong T.Y., Aung T., et al Prevalence, risk factors, and visual features of undiagnosed glaucoma: The Singapore Epidemiology of Eye Diseases Study. JAMA Ophthalmol. 2015; 133(8): 938–46. https://doi.org/10.1001/jamaophthalmol.2015.1478
  27. Chua J., Lim C.X.Y., Wong T.Y., Sabanayagam C. Diabetic retinopathy in the Asia-Pacific. Asia Pac. J. Ophthalmol. (Phila). 2018; 7(1): 3–16. https://doi.org/10.22608/apo.2017511
  28. Park K.H., Kim J.Y., Choo S.W., Yoon H.Y., Jeong S.W. Ahmed glaucoma valve implantation with Ologen® Collagen Matrix for the surgical treatment of feline glaucoma. Vet. Ophthalmol. 2018; 21(1): 96–100. https://doi.org/10.1111/vop.12422
  29. Hemminki K., Försti A., Tuuminen R., Hemminki O., Goldschmidt H., Sundquist K., et al. The incidence of senile cataract and glaucoma is increased in patients with plasma cell dyscrasias: etiologic implications. Sci. Rep. 2016; 6: 28500. https://doi.org/10.1038/srep28500
  30. Fong C.S., Mitchell P., Rochtchina E., de Loryn T., Tan A.G., Wang J.J. Visual impairment corrected via cataract surgery and 5-year survival in a prospective cohort. Am. J. Ophthalmol. 2014; 157(1): 163–70. https://doi.org/10.1016/j.ajo.2013.08.018
  31. Hashemi H., Khabazkhoob M., Nabovati P., Ostadimoghaddam H., Shafaee S., Doostdar A., et al. The prevalence of age-related eye disease in an elderly population. Ophthalmic Epidemiol. 2017; 24(4): 222–8. https://doi.org/10.1080/09286586.2016.1270335
  32. Panday M., George R., Asokan R., Ve Ramesh S., Velumuri L., Choudhari N.S., et al. Six-year incidence of visually significant age-related cataract: the Chennai eye disease incidence study. Clin. Exp. Ophthalmol. 2016; 44(2): 114–20. https://doi.org/10.1111/ceo.12636
  33. Davitt B.V., Christiansen S.P., Hardy R.J., Tung B., Good W.V. Incidence of cataract development by 6 months’ corrected age in the Early Treatment for Retinopathy of Prematurity study. J. AAPOS. 2013; 17(1): 49–53. https://doi.org/10.1016/j.jaapos.2012.10.011
  34. Aznabaev M.T. State of ophthalmic care in the Republic of Bashkortostan and ways to eliminate avoidable blindness. In: Proceedings of the Russian Interregional Symposium «Elimination of Avoidable Blindness: The WHO World Initiative» [Materialy Rossiyskogo mezhregional’nogo simpoziuma «Likvidatsiya ustranimoy slepoty: Vsemirnaya initsiativa VOZ»]. Moscow; 2003: 60–8. (in Russian)
  35. Malishevskaya O.I., Knysh O.I., Dolgova I.G., Malishevskaya T.N. Market researches of drug provision in glaucoma patients in the Tyumen region. Farmatsiya. 2015; (2): 29–32. (in Russian)
  36. Nerov V.V., Zakharova E.K., Poskachina T.R., Nazarov A.N., Kiseleva O.A., Bessmertnyy A.M., et al. Ethnic characteristics of eye structure and prevalence of primary glaucoma separate forms. Yakutskiy meditsinskiy zhurnal. 2014; (1): 57–60. (in Russian)
  37. Devyatkova A.S., Subbotina I.N. Dynamics of age-specific cataract morbidity indices in Perm Region. Permskiy meditsinskiy zhurnal. 2011; 28(3): 124–7. (in Russian)
  38. Vydrov A.S., Komarovskikh E.N. Overall and primary incidence of age-related cataract in the population of Amur region. Rossiyskiy oftal’mologicheskiy zhurnal. 2013; 6(3): 16–8. (in Russian)
  39. Bayramly A.N. Age-related macular degeneration of the retina. Academy. 2018; (8): 57–62. (in Russian)
  40. Ermilov V.V., Nesterova A.A., Makhonina O.V. Pathological correlations between the Alzheimer’s disease and age-related macular degeneration. Vestnik meditsinskikh tekhnologiy. 2013; (1): 83. (in Russian)
  41. Slepova O.S., Eremeeva E.A., Ryabina M.V., Sorozhkina E.S. Cytokines in lacrimal fluid and blood serum: early biomarkers of age-related macular degeneration. Meditsinskaya immunologiya. 2015; 17(3): 245–52. https://doi.org/10.15789/1563-0625-2015-3-245-252 (in Russian)
  42. Singer M. Advances in the management of macular degeneration. F1000Prime Rep. 2014; 6: 29. https://doi.org/10.12703/p6-29
  43. Alpatov S.A., Urneva E.M., Malyshev V.V. Age-Related Macular Degeneration [Vozrastnaya makulyarnaya degeneratsiya]. Moscow: GEOTAR-Media; 2010. (in Russian)
  44. Ermakova N.A., Rabdanova O.Ts. Main etiological factors and pathogenetic mechanisms of the development of age-related macular dystrophy. Klinicheskaya oftal’mologiya. 2007; 8(3): 125–7. (in Russian)
  45. Morrison М.А., Silveira A.S., Huynh N., Jun G., Smith S.E., Zacharaki F., et al. System biology – based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age – related macular degeneration. Hum. Genomics. 2011; 5(6): 538–68. https://doi.org/10.1186/1479-7364-5-6-538
  46. Armstrong R.A. Alzheimer’s disease and the eye. J. Optometry. 2009; 2(3): 103–11. https://doi.org/10.3921/joptom.2009.103
  47. Klein R., Knudtson M.D., Cruickshanks K.J., Klein B.E. Further observations on the association between smoking and the long-term incidence and progression of age-related macular degeneration: The Beaver Dam Eye Study. Arch. Ophthalmol. 2008; 126(1): 115–21. https://doi.org/10.1001/archopht.126.1.115
  48. Augood C.A., Vingerling J.R., Paulus T.V., de Jong PT., Chakravarthy U., Seland J., et al. Prevalence of age-related maculopathy in older Europeans. The European Eye Study (EUREYE). Arch. Ophthalmol. 2006; 124(4): 529–35. https://doi.org/10.1001/archopht.124.4.529
  49. Astakhov Yu.S., Butin E.V., Morozova N.V., Sokolov V.O., Florentseva S.S. An experience of «Retinalamin» use in glaucomatous optic neuropathy and age-related macular degeneration. Oftal’mologicheskie vedomosti. 2013; 6(2): 45–9. (in Russian)
  50. Tham Y.C., Li X., Wong T.Y., Quigley H.A., Aung T., Cheng C.Y. Global prevalence of glaucoma burden trough 2040: A systematic review and meta-analysis. Ophthalmology. 2014; 121(11): 2081–90. https://doi.org/10.1016/j.ophtha.2014.05.013
  51. Zhao M., Wu Q., Hu P., Jia L. Macular thickness assessed with optical coherence tomography in young Chinese myopic patients. J Ophthalmol. 2015; 2015: 715798. https://doi.org/10.1155/2015/715798
  52. Kim Y.K., Choi H.J., Jeoung J.W., Park K.H., Kim D.M. Five-year incadence of primary open-angleglaucoma and rate of progression in health center-based Korean population: the Gangnam Eye Study. PLoS One. 2014; 9(12): e114058. https://doi.org/10.1371/journal.pone.0114058
  53. Wostyn P., De Groot V., Van Dam D., Audenaert K., Killer H.E., De Deyn P.P. The glymphatic hypothesis of glaucoma: a unifying concept incorporating vascular, biomechanical, and biochemical aspects of the disease. BioMed Res. Int. 2017; 2017: 5123148. https://doi.org/10.1155/2017/5123148
  54. Levkovitch-Verbin H., Goldshtein I., Chodick G., Zigman N., Shalev V. The Maccabi Glaucoma Study: prevalence and incidence of glaucoma in a large Israeli health maintenance organization. Am. J. Ophtalmol. 2014; 158(2): 402–8. https://doi.org/10.1016/j.ajo.2014.04.026
  55. Markelova E.V., Khokhlova A.S., Kirienko A.V., Filina N.V., Serebryannaya N.B. The immunopathogenesis and differential markers of primary open angle ‎glaucoma and primary angle-closure glaucoma. Zhurnal nauchnykh statey «Zdorov’e i obrazovanie v XXI veke». 2016; 18(2): 613–21. (in Russian)
  56. Korsakova N.V. The primary open-angle glaucoma: modern theory of development (literature review). Uspekhi gerontologii. 2018; 31(1): 95–102. (in Russian)
  57. Paul C., Sengupta S., Chouldhury S., Banerjee S., Sleath B.L. Prevalence of glaucoma in Eastern India: The Hooghly River Glaucoma Study. Indian J. Ophtalmol. 2016; 64(8): 578–83. https://doi.org/10.4103/0301-4738.191497
  58. Nowak M.S., Smigielski J. The prevalence of age-related eye diseases and cataract syrgery among older adults in the city of Lodz, Poland. J. Ophthalmol. 2015; 2015: 605814. https://doi.org/10.1155/2015/605814
  59. Hamano T., Li X., Tanito M., Nabika T., Shiwaku K., Sundquist J., Sundquist K. Neighborhood deprivation and risk of age-related eye diseases: A Follow-up Study in Sweden. Ophthalmic Epidemiol. 2015; 22(5): 308–20. https://doi.org/10.3109/09286586.2015.1056537
  60. Aznabaev B.M., Zagidullina A.Sh., Rashitova D.R. Analysis of glaucoma incidence in the Republic of Bashkortostan. Natsional’nyy zhurnal «Glaukoma». 2017; 16(1): 55–63. (in Russian)
  61. Podyninogina V.V., Bagaev V.I., Chuprov A.D. Two aspects of one problem (results of questionnaire analysis in glaucoma patients). Oftal’mologicheskie vedomosti. 2015; 8(4): 76–80. (in Russian)

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Konyaev D.A., Popova E.B., Titov A.A., Agarkov N.M., Yablokov M.M., Aksenov V.V., 2021

Creative Commons License
Este artigo é disponível sob a Licença Creative Commons Atribuição 4.0 Internacional.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ:  ПИ № ФС77-50668 от 13.07.2012 г.